Occupational and Environmental Medicine, Vol 56, 181-190

Mortality patterns among workers exposed to acrylamide: 1994 follow up

GM Marsh, LJ Lucas, AO Youk and LC Schall
Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, PA 15261, USA. gmarsh+@pitt.edu

OBJECTIVE: To update the mortality experience of a cohort of 8508 workers with potential exposure to acrylamide at three plants in the United States from 1984-94. METHODS: Analyses of standardised mortality ratios (SMR) with national and local rates and relative risk (RR) regression modelling were performed to assess site specific cancer risks by demographic and work history factors, and exposure indicators for acrylamide and muriatic acid. RESULTS: For the 1925-94 study period, excess and deficit overall mortality risks were found for cancer sites of interest: brain and other central nervous system (CNS) (SMR 0.65, 95% confidence interval (95% CI) 0.36 to 1.09), thyroid gland (SMR 2.11, 95% CI 0.44 to 6.17), testis and other male genital organs (SMR 0.28, 95% CI 0.01 to 1.59), and cancer of the respiratory system (SMR 1.10, 95% CI 0.99 to 1.22); however, none was significant or associated with exposure to acrylamide. A previously reported excess mortality risk of cancer of the respiratory system at one plant remained increased among workers with potential exposure to muriatic acid (RR 1.50, 95% CI 0.86 to 2.59), but was only slightly increased among workers exposed or unexposed to acrylamide. In an exploratory exposure-response analysis of rectal, oesophageal, pancreatic, and kidney cancer, we found increased SMRs for some categories of exposure to acrylamide, but little evidence of an exposure-response relation. A significant 2.26-fold risk (95% CI 1.03 to 4.29) was found for pancreatic cancer among workers with cumulative exposure to acrylamide > 0.30 mg/m3.years; however, no consistent exposure-response relations were detected with the exposure measures considered when RR regression models were adjusted for time since first exposure to acrylamide. CONCLUSION: The contribution of 1115 additional deaths and nearly 60,000 person-years over the 11 year follow up period corroborate the original cohort study findings of little evidence for a causal relation between exposure to acrylamide and mortality from any cancer sites, including those of initial interest. This is the most definitive study of the human carcinogenic potential of exposure to acrylamide conducted to date.

Copyright © 1999 Occupational and Environmental Medicine
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hogervorst, J. G. F., Schouten, L. J., Konings, E. J. M., Goldbohm, R. A., van den Brandt, P. A. (2009). Lung Cancer Risk in Relation to Dietary Acrylamide Intake. JNCI J Natl Cancer Inst 101: 651-662 [Abstract] [Full Text]  
• Zhang, X (2009). Simultaneous exposure to dietary acrylamide and corn oil developed carcinogenesis through cell proliferation and inhibition of apoptosis by regulating p53-mediated mitochondria-dependent signaling pathway. Toxicol Ind Health 25: 101-109 [Abstract]  
• Hogervorst, J. G. F., Schouten, L. J., Konings, E. J. M., Goldbohm, R. A., van den Brandt, P. A. (2008). Dietary Acrylamide Intake Is Not Associated with Gastrointestinal Cancer Risk. J. Nutr. 138: 2229-2236 [Abstract] [Full Text]  
• Jin, L., Chico-Galdo, V., Massart, C., Gervy, C., De Maertelaere, V., Friedman, M., Van Sande, J. (2008). Acrylamide does not induce tumorigenesis or major defects in mice in vivo. J Endocrinol 198: 301-307 [Abstract] [Full Text]  
• Ao, L., Liu, S.-X., Yang, M.-S., Fong, C.-C., An, H., Cao, J. (2008). Acrylamide-induced molecular mutation spectra at HPRT locus in human promyelocytic leukaemia HL-60 and NB4 cell lines. Mutagenesis 23: 309-315 [Abstract] [Full Text]  
• Hogervorst, J. G, Schouten, L. J, Konings, E. J, Goldbohm, R A., van den Brandt, P. A (2008). Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am. J. Clin. Nutr. 87: 1428-1438 [Abstract] [Full Text]  
• Hogervorst, J. G., Schouten, L. J., Konings, E. J., Goldbohm, R. A., van den Brandt, P. A. (2007). A Prospective Study of Dietary Acrylamide Intake and the Risk of Endometrial, Ovarian, and Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 16: 2304-2313 [Abstract] [Full Text]  
• Swaen, G. M H, Haidar, S., Burns, C. J, Bodner, K., Parsons, T., Collins, J. J, Baase, C. (2007). Mortality study update of acrylamide workers. Occup. Environ. Med. 64: 396-401 [Abstract] [Full Text]  
• Besaratinia, A., Pfeifer, G. P. (2007). A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 28: 519-528 [Abstract] [Full Text]  
• Felton, J. S., Knize, M. G. (2006). A meat and potato war: implications for cancer etiology. Carcinogenesis 27: 2367-2370 [Abstract] [Full Text]  
• (2005). Amended Final Report on the Safety Assessment of Polyacrylamide and Acrylamide Residues in Cosmetics. International Journal of Toxicology 24: 21-50 [Abstract] [Full Text]  
• Besaratinia, A., Pfeifer, G. P. (2004). Genotoxicity of Acrylamide and Glycidamide. JNCI J Natl Cancer Inst 96: 1023-1029 [Abstract] [Full Text]  
• Dybing, E., Sanner, T. (2003). Risk Assessment of Acrylamide in Foods. Toxicol Sci 75: 7-15 [Abstract] [Full Text]  
• Granath, F., Tornqvist, M. (2003). Who Knows Whether Acrylamide in Food Is Hazardous to Humans?. JNCI J Natl Cancer Inst 95: 842-843 [Full Text]  
• Besaratinia, A., Pfeifer, G. P. (2003). Weak Yet Distinct Mutagenicity of Acrylamide in Mammalian Cells. JNCI J Natl Cancer Inst 95: 889-896 [Abstract] [Full Text]  
• GRANATH, F, EHRENBERG, L, PAULSSON, B, TORNQVIST, M, MARSH, G M, YOUK, A O, LUCAS, L J, SCHALL, L C (2001). Cancer risk from exposure to occupational acrylamide. Occup. Environ. Med. 58: 608-609 [Full Text]  
• SCHULZ, M R, HERTZ-PICCIOTTO, I, VAN WIJNGAARDEN, E, HERNANDEZ, J C, BALL, L M (2001). Amyotrophic lateral sclerosis and occupational exposure to 2,4-dichlorophenoxyacetic acid.. Occup. Environ. Med. 58: 609-610 [Full Text]